Previous publications show that Top2α level is reduced at physiological conditions such as glucose deprivation and hypoxia that are common in the tumor environment, and that this leads to decreased efficacy of the Top2-directed drugs [6]. This evidence concerns the gene TOP2A and neoplasm.